Percutek Therapeutics

Beijing Percutek Therapeutics Inc. is a national high-tech enterprise and a Zhongguan Village high-tech enterprise. It is also an innovation-leading company under Beijing's Biomedical Industry Leapfrog Development Project (G20 Project), located in Zhongguan Village High-End Medical Device Park, Beijing. Percutek Therapeutics has developed two core products: the abdominal aortic stent graft system and the thoracic aortic stent graft system, which feature globally leading technology tailored to the characteristics of aortic dissection and aortic aneurysm diseases in Chinese patients. Percutek Therapeutics owns multiple independent intellectual property rights and is a high-end medical device R&D and manufacturing company. It aims to build a platform-based innovative medical device enterprise that leads domestically and ranks among the world’s best, with a focus on cardiovascular minimally invasive products, starting with aortic stents as its core foundation. Guided by the mission to treat diseases, save lives, and promote the health of a vast number of patients, the company strives to become an industry leader in the field of cardiovascular minimally invasive treatments.